20 research outputs found
Estudo genĂ©tico-clĂnico e citogenĂ©tico de crianças autistas
Infantile autism is characterized by a typical behavior that may be caused by an organic disease or by an emotional disorder. The objective of the present genetic-clinical and cytogenetic study was to detect the presence of organic diseases, especially those of genetic etiology, that migth be related to the signs and symptons of autism presented by 17 boys who attended at the RibeirĂŁo Preto Association for Autistic Children. We concluded that 14 individuals had no organic alterations that might be related to their clinical picture; one subject presented a clinical picture compatible with macrocephaly; one subject presented a clinical picture compatible with a new X-linked mental deficiency syndorme associated with macrossomy, macrocephaly and obesity, and one subject presented the Angelman Syndrome (AS). The study of Xq27.3 fragility was also normal in all cases, excluding the presence of Fragile X syndrome in all subjects. The specific molecular study for the detection of AS revealed the presence of biparental inheritance for the markers used. Since the clinical aspects of this patient was extremely suggestive, we conclude that he represented a case of AS with biparental inheritance.O autismo infantil Ă© caracterizado pelo comportamento tĂpico que pode ser causado por uma doença orgĂąnica ou por um distĂșrbio emocional. AtravĂ©s de um estudo genĂ©tico-clĂnico e citogenĂ©tico, tivemos como objetivo detectar a presença de doenças orgĂąnicas, principalmente de etiologia genĂ©tica, que pudessem estar relacionadas com o quadro de autismo apresentado por dezessete meninos que freqĂŒentavam a
AMA de RibeirĂŁo Preto. ConcluĂmos que quatorze indivĂduos nĂŁo possuĂam alteraçÔes orgĂąnicas que pudessem estar relacionadas com o quadro clĂnico por eles apresentado; um indivĂduo apresentou quadro clĂnico compatĂvel com macrocefalia; um indivĂduo apresentou quadro clĂnico compatĂvel com uma nova sĂndrome de deficiĂȘncia mental, ligada ao X, associada Ă macrossomia, macrocefalia e obesidade, e um indivĂduo presentou a SĂndrome de Angelman (SA). O estudo citogenĂ©tico mostrou-se normal para todos os indivĂduos estudados, assim como a pesquisa de fragilidade Xq27.3, excluindo a todos da possibilidade de apresentarem a SĂndrome do X-frĂĄgil. O estudo molecular, especĂfico para a detecção da SA, revelou a presença, no paciente, de herança biparental para os marcadores utilizados; como a clĂnica desse paciente Ă© extremamente sugestiva, concluĂmos estar frente a um caso de SA com herança biparental
Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients
[EN] The association between the BTD genotype and biochemical phenotype [profound biotinidase deficiency (BD), partial BD or heterozygous activity] is not always consistent. This study aimed to investigate the genotype-biochemical phenotype association in patients with low biotinidase activity. Methods All exons, the 5'UTR and the promoter of the BTD gene were sequenced in 72 Brazilian individuals who exhibited low biotinidase activity. For each patient, the expected biochemical phenotype based on the known genotype was compared with the observed biochemical phenotype. Additional non-genetic factors that could affect the biotinidase activity were also analysed. Most individuals were identified by neonatal screening (n = 66/72). When consecutive results for the same patient were compared, age, prematurity and neonatal jaundice appeared to affect the level of biotinidase activity. The biochemical phenotype at the time of the second blood collection changed in 11/22 patients compared to results from the first sample. Three novel variants were found: c.1337T>C (p.L446P), c.1466A>G (p.N489S) and c.962G>A (p.W321*). Some patients with the same genotype presented different biochemical phenotypes. The expected and observed biochemical phenotypes agreed in 68.5% of cases (concordant patients). The non-coding variants c.-183G>A, c.-315A>G and c.-514C>T were present in heterozygosis in 5/17 discordant patients. In addition, c.- 183G>A and c.-514C>T were also present in 10/37 concordant patients. The variants found in the promoter region do not appear to have a strong impact on biotinidase activity. Since there is a disparity between the BTD genotype and biochemical phenotype, and biotinidase activity may be affected by both genetic and non-genetic factors, we suggest that the diagnosis of BD should be based on more than one measurement of plasma biotinidase activity. DNA analysis can be of additional relevance to differentiate between partial BD and heterozygosity.SIThis study received financial support from Fundo de Incentivo Ă Pesquisa e Eventos/Hospital de ClĂnicas de Porto Alegre (FIPE-HCPA) for research materials and publication fee. Post Graduate Program in Genetics and Molecular Biology (Universidade Federal do Rio Grande do Sul) funded the translation. ECN has a commercial affiliation (CTN DiagnĂłsticos) which did not have any role or financial contribution to this research. TB have fellowship from the Coordenação de Aperfeiçoamento de Pessoal de NĂvel Superior (Capes). FS had fellowship from the Fundação de Amparo Ă Pesquisa do Estado do Rio Grande do Sul (FAPERGS). IVDS, MRSC and PASF have fellowships from the Conselho Nacional de Desenvolvimento CientĂfico e TecnolĂłgico (CNPq). HB receives a research grant of Orphan Europe. The funders did no provide support in the form of salaries for any author, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the âauthor contributionsâ section
Medical Sequencing of Candidate Genes for Nonsyndromic Cleft Lip and Palate
Nonsyndromic or isolated cleft lip with or without cleft palate (CL/P) occurs in wide geographic distribution with an average birth prevalence of 1/700. We used direct sequencing as an approach to study candidate genes for CL/P. We report here the results of sequencing on 20 candidate genes for clefts in 184 cases with CL/P selected with an emphasis on severity and positive family history. Genes were selected based on expression patterns, animal models, and/or role in known human clefting syndromes. For seven genes with identified coding mutations that are potentially etiologic, we performed linkage disequilibrium studies as well in 501 family triads (affected child/mother/father). The recently reported MSX1 P147Q mutation was also studied in an additional 1,098 cleft cases. Selected missense mutations were screened in 1,064 controls from unrelated individuals on the Centre d'Ătude du Polymorphisme Humain (CEPH) diversity cell line panel. Our aggregate data suggest that point mutations in these candidate genes are likely to contribute to 6% of isolated clefts, particularly those with more severe phenotypes (bilateral cleft of the lip with cleft palate). Additional cases, possibly due to microdeletions or isodisomy, were also detected and may contribute to clefts as well. Sequence analysis alone suggests that point mutations in FOXE1, GLI2, JAG2, LHX8, MSX1, MSX2, SATB2, SKI, SPRY2, and TBX10 may be rare causes of isolated cleft lip with or without cleft palate, and the linkage disequilibrium data support a larger, as yet unspecified, role for variants in or near MSX2, JAG2, and SKI. This study also illustrates the need to test large numbers of controls to distinguish rare polymorphic variants and prioritize functional studies for rare point mutations
Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients
<p>Abstract</p> <p>Background</p> <p>Treacher Collins syndrome (TCS) is an autosomal dominant craniofacial disorder caused by frameshift deletions or duplications in the <it>TCOF1 </it>gene. These mutations cause premature termination codons, which are predicted to lead to mRNA degradation by nonsense mediated mRNA decay (NMD). Haploinsufficiency of the gene product (treacle) during embryonic development is the proposed molecular mechanism underlying TCS. However, it is still unknown if <it>TCOF1 </it>expression levels are decreased in post-embryonic human cells.</p> <p>Methods</p> <p>We have estimated <it>TCOF1 </it>transcript levels through real time PCR in mRNA obtained from leucocytes and mesenchymal cells of TCS patients (n = 23) and controls (n = 18). Mutational screening and analysis of NMD were performed by direct sequencing of gDNA and cDNA, respectively.</p> <p>Results</p> <p>All the 23 patients had typical clinical features of the syndrome and pathogenic mutations were detected in 19 of them. We demonstrated that the expression level of <it>TCOF1 </it>is 18-31% lower in patients than in controls (<it>p < 0.05</it>), even if we exclude the patients in whom we did not detect the pathogenic mutation. We also observed that the mutant allele is usually less abundant than the wild type one in mesenchymal cells.</p> <p>Conclusions</p> <p>This is the first study to report decreased expression levels of <it>TCOF1 </it>in TCS adult human cells, but it is still unknown if this finding is associated to any phenotype in adulthood. In addition, as we demonstrated that alleles harboring the pathogenic mutations have lower expression, we herein corroborate the current hypothesis of NMD of the mutant transcript as the explanation for diminished levels of <it>TCOF1 </it>expression. Further, considering that <it>TCOF1 </it>deficiency in adult cells could be associated to pathologic clinical findings, it will be important to verify if TCS patients have an impairment in adult stem cell properties, as this can reduce the efficiency of plastic surgery results during rehabilitation of these patients.</p
TGFA/Taq I polymorphism and environmental factors in non-syndromic oral clefts in Southern Brazil
Intellectual Disability in a Birth Cohort: Prevalence, Etiology, and Determinants at the Age of 4 Years
Searching for Genes for Cleft Lip and/or Palate Based on Breakpoint Analysis of a Balanced Translocation t(9;17)(q32;q12)
Recommended from our members
Targeted Resequencing of Deafness Genes Reveals a Founder MYO15A Variant in Northeastern Brazil
Summary
Identifying the genetic etiology in a person with hearing loss (HL) is challenging due to the extreme genetic heterogeneity in HL and the populationâspecific variability. In this study, after excluding GJB2 variants, targeted resequencing of 180 deafnessârelated genes revealed the causative variants in 11 of 19 (58%) Brazilian probands with autosomal recessive HL. Identified pathogenic variants were in MYO15A (10 families) and CLDN14 (one family). Remarkably, the MYO15A p.(Val1400Met) variant was identified in eight families from the city of Monte Santo in the northeast region of Brazil. Haplotype analysis of this variant was consistent with a single founder. No other cases with this variant were detected among 105 simplex cases from other cities of northeastern Brazil, suggesting that this variant is confined to a geographical region. This study suggests that it is feasible to develop populationâspecific screening for deafness variants once causative variants are identified in different geographical groups